Myriad Genetics Inc
Nasdaq · Healthcare · In Vitro & In Vivo Diagnostic Substances · Salt Lake City, UT
MYGN chart
What traders are saying about $MYGN
Latest postsMyriad Genetics Inc news
- Myriad Genetics at UBS Global Healthcare Conference: oncology pivot deepens
Investing.com UK ·
- Form 4 Myriad Genetics Inc: Jennifer Lynne Fox (Chief Legal & Corp Strategy) For: 6 November By Investing.com
Investing.com India ·
- Myriad Genetics EVP Vishal Sikri Awarded 53,236 Retention Stock Options
Kalkine Media ·
- Myriad Genetics Grants Retention Stock Options to Executives
TipRanks ·
- Retention options for three Myriad Genetics (MYGN) executives vest after three years, subject to service.
Stock Titan ·
- Myriad Genetics, Inc. (MYGN) Stock Price, News, Quote & History
Yahoo! Finance Canada ·
- Myriad Genetics, Inc. (MYGN) stock price, news, quote and history
Yahoo Finance UK ·
- Myriad Genetics’s Q3 2026 earnings call: our top 5 analyst questions
Yahoo Finance ·
- Regulatory Hurdles Put Myriad Genetics’ $210 Million Prenatal Health Sale to LabCorp at Risk
TipRanks ·
- AMP v. Myriad Genetics: Gene Patent Ruling
CASRAI ·
- Myriad Genetics raises 2026 revenue outlook ami...
Pluang ·
- Q3 revenue slips to $202.7M as Myriad Genetics (MYGN) posts a wider net loss.
Stock Titan ·
Myriad Genetics Inc key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $824.5M | $837.6M | $753.2M | $678.4M |
| Net income | -$366.0M | -$127.0M | -$263.0M | -$112.0M |
| Diluted EPS | $-3.95 | $-1.41 | $-3.18 | $-1.39 |
| Total assets (year end) | $706.6M | $1.03B | $1.15B | $1.20B |
| Cash and equivalents (year end) | $149.6M | $102.4M | $132.1M | $56.9M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Myriad Genetics Inc
- Ticker
- MYGN (Nasdaq)
- Industry
- In Vitro & In Vivo Diagnostic Substances
- Headquarters
- Salt Lake City, UT
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 899923
- Former names
- MYRIAD GENETICS INC
Frequently asked questions
What exchange is Myriad Genetics Inc listed on?
Myriad Genetics Inc trades on the Nasdaq under the ticker symbol MYGN.
What industry is Myriad Genetics Inc in?
Myriad Genetics Inc is classified by the SEC under "In Vitro & In Vivo Diagnostic Substances", part of the Healthcare sector on StockTweeting.
Where is Myriad Genetics Inc headquartered?
Myriad Genetics Inc's business address on file with the SEC is in Salt Lake City, UT.
When does Myriad Genetics Inc's fiscal year end?
Myriad Genetics Inc's fiscal year ends on December 31.
How much revenue did Myriad Genetics Inc report?
Myriad Genetics Inc reported $824.5M in revenue for calendar year 2025, according to its SEC filings.